Literature DB >> 9468328

The effect of corticosteroids on serum sialyltransferase enzyme activities in the rat.

T M Maguire1, C M Coughlan, J R Seckl, K C Breen.   

Abstract

Previous studies have demonstrated corticosteroid regulation of sialyltransferase (sialyl-T) enzyme activities in a number of different tissues throughout the body. In this study we examined the regulatory effect of corticosteroids on serum enzyme activity in the rat. The total serum sialyl-T activity was not affected by a decrease in corticosteroid levels following adrenalectomy. However, while there was a significant increase in enzyme activity following dexamethasone treatment, aldosterone had no effect on this parameter. Subsequent examination of individual sialyl-T enzymes demonstrated a slight decrease in alpha2,6 sialyl-T activity following adrenalectomy which was restored to basal levels following dexamethasone treatment. The activity of the alpha2,3 sialyl-T enzyme was not affected by adrenalectomy or dexamethasone treatment, but was stimulated significantly by aldosterone. In general, the levels of serum sialoglycoproteins mirrored well the activities of the appropriate sialyl-T enzymes. These results demonstrate that serum sialyltransferase activity in the rat is under the influence of circulating corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9468328     DOI: 10.1016/s0304-4165(97)00077-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Role for hepatic and circulatory ST6Gal-1 sialyltransferase in regulating myelopoiesis.

Authors:  Mark B Jones; Mehrab Nasirikenari; Li Feng; Marina T Migliore; Kyoung-Soo Choi; Latif Kazim; Joseph T Y Lau
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

2.  ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function.

Authors:  Daniel R Christie; Faheem M Shaikh; John A Lucas; John A Lucas; Susan L Bellis
Journal:  J Ovarian Res       Date:  2008-10-01       Impact factor: 4.234

3.  Blood plasma/IgG N-glycome biosignatures associated with major depressive disorder symptom severity and the antidepressant response.

Authors:  Dong Ik Park; Jerko Štambuk; Genadij Razdorov; Maja Pučić-Baković; Daniel Martins-de-Souza; Gordan Lauc; Christoph W Turck
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

4.  IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis.

Authors:  Susanna L Lundström; Aase H Hensvold; Dorothea Rutishauser; Lars Klareskog; A Jimmy Ytterberg; Roman A Zubarev; Anca I Catrina
Journal:  Arthritis Res Ther       Date:  2017-08-09       Impact factor: 5.156

5.  The Paired Siglecs in Brain Tumours Therapy: The Immunomodulatory Effect of Dexamethasone and Temozolomide in Human Glioma In Vitro Model.

Authors:  Przemyslaw Wielgat; Natalia Wawrusiewicz-Kurylonek; Robert Czarnomysy; Karol Rogowski; Krzysztof Bielawski; Halina Car
Journal:  Int J Mol Sci       Date:  2021-02-11       Impact factor: 5.923

6.  Altered Fc galactosylation in IgG4 is a potential serum marker for chronic lung disease.

Authors:  Tina Heyder; Emil Wiklundh; Anders Eklund; Anna James; Johan Grunewald; Roman A Zubarev; Susanna L Lundström
Journal:  ERJ Open Res       Date:  2018-07-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.